VHU

(4M)-4-(2-{4-[(3S)-1-acetylpiperidine-3-carbonyl]piperazine-1-carbonyl}-1-benzofuran-7-yl)-1H-isoindol-1-one

Created:	2023-09-12
Last modified:	2024-03-27

Find Related PDB Entry
1 entries where VHU is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	1
Bond Count	71
Aromatic Bond Count	16

2D diagram of VHU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4M)-4-(2-{4-[(3S)-1-acetylpiperidine-3-carbonyl]piperazine-1-carbonyl}-1-benzofuran-7-yl)-1H-isoindol-1-one
Systematic Name (OpenEye OEToolkits)	4-[2-[4-[(3~{S})-1-ethanoylpiperidin-3-yl]carbonylpiperazin-1-yl]carbonyl-1-benzofuran-7-yl]isoindol-1-one
Formula	C₂₉ H₂₈ N₄ O₅
Molecular Weight	512.556
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CC(=O)N1CCCC(C1)C(=O)N1CCN(CC1)C(=O)c1cc2cccc(c2o1)c1cccc2C(=O)N=Cc21
SMILES	CACTVS	3.385	CC(=O)N1CCC[CH](C1)C(=O)N2CCN(CC2)C(=O)c3oc4c(cccc4c5cccc6C(=O)N=Cc56)c3
SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCCC(C1)C(=O)N2CCN(CC2)C(=O)c3cc4cccc(c4o3)c5cccc6c5C=NC6=O
Canonical SMILES	CACTVS	3.385	CC(=O)N1CCC[C@@H](C1)C(=O)N2CCN(CC2)C(=O)c3oc4c(cccc4c5cccc6C(=O)N=Cc56)c3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(=O)N1CCC[C@@H](C1)C(=O)N2CCN(CC2)C(=O)c3cc4cccc(c4o3)c5cccc6c5C=NC6=O
InChI	InChI	1.06	InChI=1S/C29H28N4O5/c1-18(34)33-10-4-6-20(17-33)28(36)31-11-13-32(14-12-31)29(37)25-15-19-5-2-8-22(26(19)38-25)21-7-3-9-23-24(21)16-30-27(23)35/h2-3,5,7-9,15-16,20H,4,6,10-14,17H2,1H3/t20-/m0/s1
InChIKey	InChI	1.06	WEKQAAWIQMMXNF-FQEVSTJZSA-N

Related Resource References

Resource Name	Reference
PubChem	171037373

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.